Prevalence and predictors of left atrial thrombosis in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants.
Filippo AngeliniPier Paolo BocchinoMattia PeyracchiaAndrea SagliettoMassimo MagnanoNicolò PatanèFabrizio D'AscenzoCarla GiustettoMatteo AnselminoFiorenzo GaitaElisabetta TosoPublished in: Acta cardiologica (2021)
Among real-world patients with non-valvular AF treated with NOACs, we found a high incidence of LA/LAA thrombi compared to previous reports. The main predictors of LA/LAA thrombosis were a CHA2DS2-VASc score > 3 and obesity.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- left atrial
- catheter ablation
- pulmonary embolism
- risk factors
- left atrial appendage
- direct oral anticoagulants
- heart failure
- insulin resistance
- metabolic syndrome
- type diabetes
- weight loss
- percutaneous coronary intervention
- weight gain
- high fat diet induced
- adverse drug
- left ventricular
- skeletal muscle
- mitral valve
- newly diagnosed
- venous thromboembolism
- body mass index